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Peripartum cerebral hypoxia and ischemia, and intrauterine infection and inflammation,
are detrimental for the precursor cells of the myelin-forming oligodendrocytes in the
prematurely newborn, potentially leading to white matter injury (WMI) with long-term
neurodevelopmental sequelae. Previous data show that hypomyelination observed in
WMI is caused by arrested oligodendroglial maturation rather than oligodendrocyte-
specific cell death. In a rat model of premature WMI, we have recently shown that
small extracellular vesicles (sEV) derived from Wharton’s jelly mesenchymal stromal
cells (WJ-MSC) protect from myelination deficits. Thus, we hypothesized that sEV
derived from WJ-MSC directly promote oligodendroglial maturation in oligodendrocyte
precursor cells. To test this assumption, sEV were isolated from culture supernatants
of human WJ-MSC by ultracentrifugation and co-cultured with the human immortalized
oligodendrocyte precursor cell line MO3.13. As many regulatory functions in WMI have
been ascribed to microRNA (miR) and as sEV are carriers of functional miR which can
be delivered to target cells, we characterized and quantified the miR content of WJ-
MSC-derived sEV by next-generation sequencing. We found that WJ-MSC-derived sEV
co-localized with MO3.13 cells within 4 h. After 5 days of co-culture, the expression
of myelin basic protein (MBP), a marker for mature oligodendrocytes, was significantly
increased, while the oligodendrocyte precursor marker platelet-derived growth factor
alpha (PDGFRα) was decreased. Notch and MAPK/ERK pathways known to inhibit
oligodendrocyte maturation and differentiation were significantly reduced. The pathway
enrichment analysis showed that the miR present in WJ-MSC-derived sEV target genes
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having key roles in the MAPK pathway. Our data strongly suggest that sEV from WJ-
MSC directly drive the maturation of oligodendrocyte precursor cells by repressing
Notch and MAPK/ERK signaling.
Keywords: mesenchymal stromal cells, Wharton’s jelly, small extracellular vesicles, premature white matter injury,
oligodendroglial maturation, ERK, Notch, microRNA
INTRODUCTION
White matter injury (WMI) is the most common cerebral
abnormality in premature neonates. Thanks to improved
peripartum care in preterm birth, the number of newborns
affected by the cystic form of WMI, called cystic periventricular
leukomalacia (PVL), has become very low nowadays (Hamrick
et al., 2004). However, the non-cystic and mostly diffuse type
of cerebral WMI remains predominant in very preterm-born
infants (Inder et al., 2003; Hamrick et al., 2004; Horsch et al.,
2007). The frequency of preterm WMI, counting both cystic
and non-cystic, is 39.6% in infants born before gestational week
28, 27.4% before week 32, and 7.3% before week 37 (Romero-
Guzman and Lopez-Munoz, 2017). Long-term neurological
consequences are typically cerebral palsy in cystic WMI and
cognitive deficits and impairments in attention, behavior, or
socialization in diffuse cerebral WMI (Agut et al., 2020).
The pathophysiology of premature WMI is complex.
However, it is generally accepted to relate to both fetal
cerebral hypoxia and ischemia and intrauterine infection and
inflammation causing downstream excitotoxicity and oxidative
stress, which are harmful to the maturing myelin-forming
oligodendrocyte lineage (Khwaja and Volpe, 2008; Volpe,
2008). Unfortunately, today no effective therapy for preterm
WMI is available.
In preclinical models of premature WMI, mesenchymal
stromal cell (MSC)-based therapy turned out to be an effective
treatment, in which the beneficial effects rely to a great extent on
secreted extracellular vesicles (EV) (Katsuda et al., 2013; Lener
et al., 2015). According to their size, EV can be distinguished
between small EV (sEV) (50–150 nm in diameter), also known
as exosomes, and microvesicles (≤1,000 nm in diameter) (Théry
et al., 2018; Rohde et al., 2019). EV can transfer at least parts of
the biological properties of their mother cells by releasing their
cargo, consisting of proteins, lipids and nucleic acids, into their
target cell (van Niel et al., 2018). The use of EV as biological
treatment has several advantages over classical cell-based therapy.
EV are not viable, making it less complex to store them and to
standardize the applied dose together with the biological activity.
Furthermore, they are not tumorigenic and less immunogenic
than proliferating cells.
Pre-clinically, MSC-derived EV have been proven to display
neuroprotective and –regenerative effects comparable to their
cells of origin (Vizoso et al., 2017). For instance, in ovine
fetuses, MSC-derived EV reduced the hypo-myelination and
improved the brain functions in a model of perinatal brain
injury (Ophelders et al., 2016). In a rat model of premature
brain injury induced by inflammation, the treatment with
MSC-derived EV restored white matter microstructure and
myelination (Drommelschmidt et al., 2017). We have recently
shown that intranasal administration of sEV derived from
MSC isolated from the umbilical cord connective tissue, called
Wharton’s jelly (WJ), reduced WMI in a preclinical rat model of
premature brain injury (Thomi et al., 2019a). In accordance with
others, we further provided strong pieces of evidence that the
WMI in premature brains is caused by disturbed oligodendrocyte
maturation rather than the cell death of the oligodendrocyte
lineage (Buser et al., 2012; Oppliger et al., 2016; van Tilborg et al.,
2018; Thomi et al., 2019a).
A crucial role in neurodevelopment and -regeneration
has been ascribed to microRNAs (miR), which–besides other
functional molecules–can be delivered by sEV to their recipient
cells and exert their task. MicroRNAs have first been described in
1993 by Lee and coworkers in C. elegans (Lee et al., 1993). They
are short non-coding RNAs, which are highly conserved across
species. The key function of miR is posttranscriptional gene
regulation leading to the cleavage, translational repression or
deadenylation of the target genes (Winter et al., 2009). Thereby,
the miR bind to the 3′ UTR of the repressing mRNA forming
the so-called RNA-induced silencing (RISC) complex. Because of
their crucial role in gene silencing, we hypothesize that WJ-MSC-
derived sEV contain miR that interfere with signaling pathways
involved in WMI.
Based on these findings, we aimed to explore the
neuroregenerative potential of WJ-MSC-derived sEV in WMI
by analyzing their effect on the maturation of oligodendroglial
progenitor (OPC)-like cells and the characterization and
quantification of the miR cargo of sEV.
MATERIALS AND METHODS
Isolation of sEV Derived From Human
Wharton’s Jelly-Derived Mesenchymal
Stromal Cells (WJ-MSC)
After cesarean section, umbilical cords from healthy term
deliveries (gestational age ≥ 37 weeks) were collected from
patients after obtaining informed consent. The study was
approved by the Ethics Committee of the Canton of Bern
(reference numbers: KEK BE 090_07 and KEK BE 178_03).
Human WJ-MSC were isolated from the umbilical cord
connective tissue, the so-called Wharton’s jelly, via enzymatic
digestion as previously described (Joerger-Messerli et al., 2018).
The cells were expanded in Dulbecco’s modified Eagle’s medium
(DMEM)/F12 supplemented with 10% fetal bovine serum
(FBS), 2 mmol/L GlutaMAXTM, 100 units/mL penicillin and
100 µg/mL streptomycin (Thermo Fisher Scientific, Waltham,
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MA, United States). The WJ-MSC’s identity is regularly
confirmed, as we have previously published (Messerli et al.,
2013; Thomi et al., 2019b). At passage 4–6, WJ-MSC were
split into eight T150 cm2 cell culture flasks and cultured until
they reached 80% confluency. Then, the cells were washed
twice with PBS, and the medium was replaced with serum-free
DMEM/F12, supplemented with 2 mmol/L GlutaMAXTM, 100
units/mL penicillin, and 100 µg/mL streptomycin. After 36 h of
incubation, culture supernatants were collected and sEV were
isolated by serial centrifugations according to the protocol of
Théry et al. (2006). The pelleted sEV were retrieved in PBS and
stored at −80◦C. The sEV were characterized according to their
morphology, size, and endosomal marker expression, as we have
recently published (Thomi et al., 2019b).
Culture of MO3.13 Cells With
WJ-MSC-Derived sEV
The human oligodendrocytic hybrid cell line MO3.13 was
expanded in Dulbecco’s Modified Eagle’s Medium (DMEM)
supplemented with 10% FBS, 2 mmol/L GlutaMAXTM, 100
units/mL penicillin, and 100 mg/mL streptomycin. The cells were
detached by adding 0.25% trypsin/EDTA.
For the culture with WJ-MSC-derived sEV, MO3.13 cells were
seeded at a density of 3,500 cells/cm2. MO3.13 cells were let to
adhere overnight. The next day, sEV (0.5 µg/mL) were added
and cultured for 5 days. On day 3, the medium was changed, and
fresh sEV (0.5 µg/mL) were added. As a control, the cells were
cultured without sEV.
To analyze the interaction between sEV and MO3.13, sEV
were stained with 2× 10−6 M PKH26 (Sigma-Aldrich, St. Louis,
MO, United States) as we have recently described (Thomi et al.,
2019b). MO3.13 were seeded at a density of 2,500 cells/cm2 in
Nunc R© Lab-Tek R© 2-chamber slides (Sigma-Aldrich). To avoid
overgrowth and properly detect interactions between single
MO3.13 and sEV, the cells were seeded less dense than for the
experiments described above. The next day, PKH26-labeled sEV
were co-cultured with MO3.13 for 4 h.
Immunocytochemistry
After co-culture of MO3.13 cells and sEV, the cells were
fixed with 4% paraformaldehyde and blocked with 1% bovine
serum albumin (BSA; Sigma-Aldrich) and 0.25% Triton X-
100 (Sigma-Aldrich) in PBS for 1 h at room temperature.
MO3.13 were stained overnight at 4◦C with antibodies against
the following proteins: β-tubulin (1:200, ab6046, Abcam,
Cambridge, United Kingdom), galactocerebrosidase (GalC,
1:500, G9152, Sigma-Aldrich), 2′,3′-cyclic-nucleotide 3′-
phosphodiesterase (CNPase, 1:100, C5922, Sigma-Aldrich),
myelin basic protein (MBP, 1:200, ab40390, Abcam), and
myelin-associated glycoprotein (MAG, 1:400, ab89780, Abcam).
For the detection, anti-rabbit IgG Alexa Fluor 488 antibody
(1:200, Thermo Fisher Scientific) and anti-mouse IgG Alex
Fluor 594 antibody (1:200, Thermo Fisher Scientific) were used
and incubated for 1 h at room temperature. 4′,6-diamidino-
2′-phenylindole-dihydrochloride (DAPI; Sigma-Aldrich) was
used to counterstain the nuclei. Images were either acquired
on a DM6000 B microscope (Leica Microsystems, Wetzlar,
Germany), or on a laser scanning microscope (Carl Zeiss LSM
710, Oberkochen, Germany) and processed using the Zeiss ZEN
lite imaging software version 3.3 (Carl Zeiss). Randomly selected
fields of vision (n = 14) were chosen to calculate the percentage
of PKH26-positive MO3.13 cells relative to the number of
DAPI-positive nuclei.
RNA and Protein Extraction
RNA and protein of WJ-MSC were isolated by the use of the
QIAshredder and the Allprep DNA/RNA/Protein Mini Kit
according to the manufacturers’ protocol (Qiagen, Hilden,
Germany). Total Exosome RNA and Protein Isolation Kit
(Thermo Fisher Scientific) was used to extract the total RNA
of WJ-MSC-derived sEV according to the manufacturers’
instructions. RNA concentration was measured by NanoVue
PlusTM spectrophotometer (Biochrom, Holliston, MA,
United States). The Bicinchoninic Acid Protein Assay Kit
(Sigma-Aldrich) was used for the determination of the total
protein concentration of WJ-MSC.
Reverse Transcription and Real-Time
Polymerase Chain Reaction (PCR)
The reverse transcription of mRNA was done with up to 3 µg
RNA using the SuperScript VI First-Strand Synthesis System
(Thermo Fisher Scientific). Gene expression was measured by
real-time RT-qPCR using the primercon assays listed in Table 1.
The following PCR cycling program was run on a QuantStudio
TM7 Flex Real-Time PCR System (Thermo Fisher Scientific):
2 min at 50◦C, 10 min at 95◦C, followed by 45 cycles of 15 s at
95◦C and 1 min at 60◦C. The housekeeping gene glyceraldehyde-
3-phosphate dehydrogenase was used as an endogenous control.
Analysis of all real-time PCR reactions was done using the
QuantStudioTM 7 Flex Real-Time PCR System Software. Data
were expressed as fold change relative to commercial total human
RNA (Thermo Fisher Scientific).
Western Blot Analysis
Extracted proteins were separated by sodiumdodecylsulfate–
polyacrylamide gel electrophoresis (SDS-PAGE) on a 4–20%
gradient gel (Bio-Rad, Hercules, CA, United States), transferred
to nitrocellulose membranes (Thermo Fisher Scientific), and
blocked either with 5% non-fat dry milk (NFDM) or 5% bovine
serum albumin (BSA, Sigma-Aldrich) dissolved in Tris-buffered
saline (TBS). The following proteins were analyzed: Cleaved
Notch1 (4147, Cell Signaling Technology, Inc., Danvers, MA,
United States), platelet-derived growth factor receptor-alpha
(PDGFRα, ab61219, Abcam), myelin basic protein (Mbp,
AB980, Thermo Fisher Scientific), proliferating-cell-nuclear-
antigen (PCNA, 2586, Cell Signaling Technology), Erk1/2
(9102, Cell Signaling Technology), Phospho-Erk1/2 (9101,
Cell Signaling Technology), β-Tubulin (ab6046, Abcam).
Horseradish peroxidase-coupled donkey anti-rabbit or
sheep anti-mouse antibodies (Cytiva, Marlborough, MA,
United States) were used as secondary antibodies. Binding was
detected using the chemiluminescent Amersham ECL Prime
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TABLE 1 | Primers and probes or gene expression assays used for real-time RT-qPCR.
Gene Description Assay ID/Primers and probe sequences Homo sapiens
HES5 Hes family bHLH transcription factor 5 Hs01387463_g1
MAPK1 Mitogen-activated protein kinase 1 Hs01046830_m1
MBP Myelin basic protein F: 5′-ACTATCTCTTCCTCCCAGCTTAAAAA-3′
R: 5′-TCCGACTATAAATCGGCTCACA-3′
P: 5′-TGGGCATCGACTCCCTTGAATCCC-3′
NOTCH1 Notch homolog 1 F: 5′-TGCATGATGCCTACATTTCAAGA-3′
R: 5′-TTCAGTATTATGTAGTTGTTCGTTGGTTATAC-3′
P: 5′-TGGTTCTGGAGGGACC-3′
NOTCH2 Notch homolog 2 Hs01050702_m1
NRAS Neuroblastoma RAS viral oncogene homolog Hs00180035_m1
PDGFRα Platelet-derived growth factor receptor alpha Hs00998018_m1
F, Forward Primer; R, Reverse Primer; P, Probe.
western Blotting Detection Reagent (Cytiva) on a Chemidoc
XRS + system (Bio-Rad). Pixel summation of individual
bands was performed with ImageJ Software (NIH, Bethesda,
MD, United States).
RNA Sequencing and Bioinformatics
Processing
Genome-wide profiling of paired WJ-MSC and WJ-MSC-derived
sEV from the same individual (n = 6) was done by preparing
small RNA libraries, and sequencing on a Illumina HiSeq 4000
sequencing system (Illumina, San Diego, CA, United States) by
Fasteris SA (Plan-les-Ouates, Switzerland). We used MirDeep2
v. 0.1.2 (Friedlander et al., 2012) to map the reads to the human
reference genome (GRCh38) and count the number of reads per
known miRNA (miRBase v. 22).
Functional Analysis of sEV-Derived miR
A volcano plot presenting up- and down-regulated miR in sEV
relative to their parental cells was done using R (R Core Team,
2020). To create heatmaps showing the expression of the most
abundant miR (mean normalized counts >10,000) in sEV relative
to WJ-MSC and vice versa, we used the freely available web
server Heatmapper (Babicki et al., 2016). The FunRich functional
enrichment analysis tool version 3.1.3 was used to create a Venn
diagram (Pathan et al., 2015; Pathan et al., 2017).
Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway
enrichment analysis of miR in sEV with ≥10,000 mean
normalized counts was performed using DIANA-miRPath 3.0
web-server (Vlachos et al., 2015). The rich factor was calculated
as the ratio of the number of targeted genes divided by the
number of all the genes in each pathway. The Q-value is the False
Discovery Rate (FDR)-adjusted p-value. The results were shown
as a scatter plot using R (R Core Team, 2020). To illustrate a
miR-mRNA network, Cytoscape software version 3.7.1 was used
(Shannon et al., 2003).
Statistical Analysis
The statistical analysis of the real-time PCR and western blot
results have been done using GraphPad Prism version 7.00 for
Windows (Graphpad Software, San Diego, California United
States, www.graphpad.com). To compare gene and protein
expression in untreated and sEV-treated MO3.13 cells paired
t-test was done. p < 0.05 was considered statistically significant.
To test for significant differences in miR expression between
WJ-MSC-derived EV and WJ-MSC, DESeq2 v. 1.22.2 in R v. 3.5.2
(Love et al., 2014) was used. p-values were FDR-adjusted utilizing
the procedure of Benjamini-Hochberg (p-adj). p-adj < 0.05 was
considered statistically significant.
RESULTS
sEV Co-localize With MO3.13 Cells
Physical contact with the target cell is essential for sEV to
have a potential therapeutic effect. Therefore, PKH26-labeled
sEV were co-cultured with the immortalized oligodendrocyte
precursor cell line MO3.13. After 4 h of co-culture, confocal
microscopy revealed co-localization of PKH26-labeled sEV and
MO3.13 stained for β-tubulin (Figure 1A). sEV mostly formed
aggregates and were located in the perinuclear region, indicating
their complete internalization. The percentage of PKH26-positive
MO3.13 cells was 22.97± 20.69.
sEV Reduce PDGFRα and Induce MBP
Expression in MO3.13 Cells
We measured the expression of platelet-derived growth factor
alpha (PDGFRα) and myelin basic protein (MBP) to assess the
effect of WJ-MSC-derived sEV on the maturation of MO3.13
cells. After 5 days of co-culture with sEV, the transcription of
PDGFRα was reduced (p = 0.0339), whereas the gene expression
of MBP was increased in MO3.13 (p = 0.022) compared to
untreated MO3.13 cells (Figures 1B,C). The protein levels of
PDGFRα in MO3.13 cells were decreased as well after 5 days
of co-culture with sEV related to untreated cells (p = 0.0045)
(Figures 1D,E). Western blot analysis of MBP revealed several
signals at distinct sizes (Figure 1D). The size of the classic
MBP isoforms ranges from 14 to 21.5 kDa. Western blot
analysis showed a faint signal at a size of 20 kDa representing
monomeric MBP isoforms (mMBP). The MBP signals between
25 and 50 kDa, and 50 and 75 kDa, respectively, are most
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FIGURE 1 | WJ-MSC-derived sEV co-localize with MO3.13 cells and drive their maturation. (A) Representative confocal Z-stack section after co-culture of sEV with
MO3.13 cells for 4 h. To label sEV, the fluorescent membrane dye PKH26 (red) was used. MO3.13 cells were stained with β-tubulin (green). Their nuclei were
counterstained with 4′,6-diamidino-2′-phenylindole-dihydrochloride (DAPI) (blue). (B,C) Transcription of PDGFRα (n = 6) and MBP (n = 6) by MO3.13 cells either left
untreated or co-incubated with 0.5 µg/mL sEV for 5 days. (D) Representative western blots of PDGFRα and MBP expression by MO3.13 cells either left untreated or
co-cultured with 5 µg/mL sEV for 5 days. (E) Quantification of PDGFRα protein expression by MO3.13 cells after 5 days (n = 6) (F–I) Quantification of MBP protein
expression by MO3.13 cells after 5 days (n = 5). (J,K) Representative fluorescence microscopy images of either untreated or sEV-treated MO3.13 cells after 5 days
for the expression of GalC, CNPase, MBP, and MAG. Their nuclei were counterstained with DAPI. (L) Representative western blot of PCNA expression by MO3.13
cells either left untreated or co-cultured with 5 µg/mL sEV for 5 days. (M) Quantification of PCNA protein expression by MO3.13 cells after 5 days (n = 5). Data are
presented as mean ± SEM. *p < 0.05, **p < 0.01, ns, non-significant.
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likely representing dimeric MBP (dMBP) and trimeric (tMBP),
as MBP tends to self-associate (Smith, 1982). The expression of
all MBP signals together was significantly increased in MO3.13
cells upon 5 days of co-culture with sEV compared to untreated
cells (p = 0.022) (Figures 1F–I). Immunofluorescent stainings
showed that untreated MO3.13 expressed GalC and CNPase.
The co-culture of MO3.13 cells with sEV for 5 days intensified
the signal of CNPase (Figure 1J). In contrast, there was
nearly no expression of MBP and MAG) in untreated MO3.13
cells, which was clearly increased upon sEV treatment for
5 days (Figure 1K). Furthermore, as the decreasing proliferation
of cells is a further sign of maturation, we measured the
proliferating-cell-nuclear-antigen (PCNA) protein expression in
untreated and sEV co-cultured MO3.13 cells. Surprisingly, the
protein levels of PCNA tended to enhance in sEV-treated
MO3.13 compared to untreated cells after 5 days of culture
(Figure 1L). However, this observed increase was not statistically
significant (Figure 1M).
sEV Reduce the Notch Signaling
Pathway in MO3.13 Cells
Notch signaling is well known as a key negative regulator of
oligodendroglial maturation (Wang et al., 1998). Therefore,
we assessed whether WJ-MSC-derived sEV promote
oligodendroglial maturation by inhibiting the activation of
Notch pathway. Upon activation, the intracellular membrane-
bound Notch transcription factor, known as NICD, gets cleaved,
translocates to the nucleus and promotes transcription of Notch
target genes. However, sEV significantly reduced the cleavage of
NICD in MO3.13 cells compared to untreated cells (p = 0.0040)
upon 5 days of culture (Figures 2A,B).
Furthermore, sEV significantly decreased the transcription of
NOTCH1 (p = 0.0247), NOTCH2 (p = 0.0430), and the Notch
target gene HES5 (p = 0.0381) in MO3.13 cells after 5 days of
co-culture relative to untreated MO3.13 cells (Figures 2C–E).
sEV Reduce the MAPK/ERK Signaling
Pathway in MO3.13 Cells
A more recently identified negative regulator of oligodendrocyte
differentiation is the MAPK/ERK pathway (Suo et al., 2019;
Allan et al., 2021). The MAPK/ERK signaling comprises the
activation of RAS, including NRAS, and a subsequent kinase
cascade leading, among others, to the phosphorylation of
ERK1/2. As shown in Figures 3A,B, the ratio of phosphorylated
(p)ERK/ERK was significantly decreased in MO3.13 cells
following co-culture with sEV for 5 days relative to untreated
cells (p = 0.0087). In addition, the transcription of NRAS
(p = 0.0500) and MAPK1 (p = 0.0377), encoding for ERK2,
was significantly reduced upon the culture of MO3.13 cells
with sEV compared to untreated cells (Figures 3C,D). The
gene expression of TP53 (p = 0.0343), encoding for p53,
which is known to functionally interact with the MAPK/ERK
pathway, was significantly decreased in MO3.13 cells upon
co-culture with sEV for 5 days compared to untreated
cells (Figure 3E).
Expression of Mature miR in WJ-MSC
and Their Derived sEV
To assess whether Notch and MAPK/ERK pathways in MO3.13
could be regulated by sEV-derived miR, Illumina NextSeq
Sequencing was done. WJ-MSC and their derived sEV have
been analyzed for the expression of 2,656 known miR. In
sEV, 850 miR with mean normalized counts from 1 to more
than 10,000 were identified. Thereof, 213 were significantly up-
regulated (p-adj < 0.05) in WJ-MSC-derived sEV compared
to their donor cells, while 120 were down-regulated (p-
adj < 0.05) (Figure 4A). To identify the most prevalent miR
in WJ-MSC and their derived sEV, we set the lower limit
of mean normalized counts to 10,000. We found 32 miR
with >10,000 mean normalized counts in sEV, and 41 in WJ-MSC
(Figures 4B,C).
A Venn diagram was generated using the datasets of the miR
that were up-regulated in sEV compared to WJ-MSC (EV up),
miR that were down-regulated in sEV compared to WJ-MSC (EV
down) and miR that yielded >10,000 mean normalized counts in
either sEV (EV >10,000 counts) or WJ-MSC (WJ-MSC >10,000
counts) to identify miR, which were either unique to a certain
data set or common to several datasets (Figure 4D). Five of
the 213 miR that were up-regulated in sEV relative to their
parent cells revealed >10,000 mean normalized counts. Three of
these 5 miR, namely miR-143-3p, miR-186-5p, and miR-21-3p,
were highly expressed in WJ-MSC as well. Furthermore, 30 miR
with >10,000 mean normalized counts were common to WJ-
MSC and sEV. In WJ-MSC as well as sEV the miR with the largest
mean normalized count was miR-22-3p (WJ-MSC: 517,157.11
counts; sEV: 268,999.81 counts).
For the following KEGG pathway enrichment analysis, miR in
sEV with >10,000 mean normalized counts were included.
WJ-MSC-Derived sEV miR Target Genes
Involved in MAPK and Notch Signaling
Pathways
KEGG pathway enrichment analysis was done with the
32 most expressed sEV miR (>10,000 mean normalized
counts) and revealed 77 significantly enriched signaling
pathways, of which 29 pathways were directly assigned to a
disease (Figures 5A,B). Among the pathways, which were
not specifically attributed to a disease, the keratan sulfate
biosynthesis pathway was the pathway with the highest rich
factor. Keratan sulfate is a sulfated glycosaminoglycan and
known to promote glial scar formation, thereby inhibiting
axon regeneration after brain injury (Zhang et al., 2006).
Furthermore, the MAPK signaling pathway, as well as the
dorso-ventral axis formation pathway, including Notch
signaling, were significantly enriched, in which 154 out of
249 genes and 21 out of 28 genes, respectively, were targeted by
WJ-MSC-derived sEV miR.
Target genes of WJ-MSC-derived sEV miR were also highly
associated with other pathways closely related to premature
WMI and oligodendroglial maturation, including the dorso-
ventral axis formation pathway, TNF signaling pathway, TGF-
beta signaling pathway, p53 signaling pathway, apoptosis, FoxO
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FIGURE 2 | WJ-MSC-derived sEV drive oligodendrocyte maturation in MO3.13 cells by reducing Notch signaling. (A) Representative western blot of Notch1 and
Cleaved Notch1 (NICD) levels in MO3.13 cells either left untreated or co-cultured with 0.5 µg/mL sEV for 5 days. (B) Quantification of the Notch1/NICD ratio (n = 5).
(C–E) Transcription of NOTCH1 (n = 6), NOTCH2 (n = 6), and HES5 (n = 5) by MO3.13 cells either left untreated or co-cultured with 0.5 µg/mL sEV for 5 days. Data
are presented as mean ± SEM. *p < 0.05, **p < 0.01.
signaling pathway, Wnt signaling pathway, HIF-1 signaling
pathway, neurotrophin signaling pathway, and regulation of actin
cytoskeleton (Figure 5A).
Among disease-related signaling cascades, proteoglycans
in cancer were revealed to exhibit the highest rich factor
(Figure 5B). Further enriched disease-attributed pathways
included the signaling cascades ascribed to glioma, Huntington’s
disease, prions disease, HTLV-1 infection, and Epstein-Barr
virus infection (Figure 5B). HTLV-1 infection and Epstein-
Barr virus infection are both associated with demyelinating
diseases, namely HTLV-1 associated myelopathy (Osame et al.,
1986; Bangham et al., 2015) and multiple sclerosis, respectively
(Guan et al., 2019).
The genes encoding for NRAS and MAPK1 (ERK2), two key
players of the MAPK/ERK pathway, were targeted by 14 and 13
highly expressed WJ-MSC-sEV miR, respectively (Figure 5C).
TP53, also being interconnected with the MAPK/ERK signaling
pathway, was targeted by 11 WJ-MSC-sEV miR. NOTCH1 and
NOTCH2 turned out to be predicted targets for 5 and 8 WJ-MSC-
sEV miR, respectively.
Mature miR-486-5p and miR-654-3p, which were significantly
up-regulated in WJ-MSC-sEV relative to their parental cells,
target NRAS, and MAPK1 and NOTCH2, respectively.
Furthermore, according to the KEGG pathway enrichment
analysis NRAS, MAPK1, TP53, NOTCH2, and NOTCH1 are
predicted targets of WJ-MSC-sEV miR-22-3p, miR-181a-5p,
miR-27b-3p, and miR-30a-5p. The four let-7 family members
(let-7a-5p, let-7e-5p, let-7f-5p, and let-7i-5p) highly expressed
in WJ-MSC-sEV were expected to target the 3 MAPK pathway
members NRAS, MAPK1, and TP53 (Figure 5C).
DISCUSSION
In fetal brain development, the maturation of the myelin-
forming oligodendrocytes is precisely timed to differentiate
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FIGURE 3 | WJ-MSC-derived sEV drive oligodendrocyte maturation in MO3.13 cells by reducing MAPK/ERK signaling. (A) Representative western blot of ERK and
phosphorylated ERK (pERK) levels in MO3.13 cells either left untreated or co-cultured with 0.5 µg/mL sEV for 5 days. (B) Quantification of the ERK/pERK ratio of
n = 4 replicates. (C–E) Transcription of NRAS (n = 5), MAPK1 (n = 6), and TP53 (n = 6) by MO3.13 cells either left untreated or co-cultured with 0.5 µg/mL sEV for
5 days. Data are presented as mean ± SEM. *p < 0.05, **p < 0.01.
into mature myelin-generating oligodendrocytes. As myelination
starts only in the third trimester of pregnancy, at around
week 32 of gestation, preterm birth often leads to injury to
immature white matter (Vaes et al., 2019). Most of the cells
of the oligodendrocyte lineage in the CNS of neonates born
between gestational weeks 24–32 are in the stages of immature
OPC and pre-oligodendrocytes (Back et al., 2007; Volpe et al.,
2011). Inflammation and hypoxia occurring at preterm birth
have been characterized as the main causes of oligodendrocyte
progenitor cell injury (Khwaja and Volpe, 2008; Volpe, 2009;
Deng, 2010). Cerebral inflammation accompanied by the release
of free radicals, glutamate, and pro-inflammatory cytokines
(Favrais et al., 2011; Hagberg et al., 2012; van Tilborg et al.,
2016), and the absent expression of key anti-oxidant enzymes
makes the oligodendrocyte progenitors very vulnerable and leads
to their damage (Perrone et al., 2015). Although MSC have
been documented to have neuroprotective and –regenerative
potential, studies showing direct effects of MSC or their
derivatives on oligodendroglial maturation in vitro are sparse.
Clark and coworkers recently gave evidence that EV isolated
from MSC of the chorionic villous tissue drive oligodendroglial
maturation, as EV increased the transcription of key mature
oligodendrocyte markers in primary murine OPC in vitro (Clark
et al., 2019). However, studies mostly investigated the impact of
MSC on oligodendrocyte specification in neural stem/progenitor
cells, rather than on the differentiation of maturation-arrested
OPC and pre-oligodendrocytes (Steffenhagen et al., 2012;
Oppliger et al., 2017).
Here, we provide solid evidence that human WJ-MSC-derived
sEV, isolated by serial centrifugation, physically interacted with
the immortalized oligodendrocyte precursor cell line MO3.13
and directly accelerated their maturation. Our study shows that
sEV down-regulated the OPC marker PDGFRα in MO3.13
after 5 days of co-culture. Together with the transcription
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FIGURE 4 | Characterization of miR expressed in WJ-MSC and their derived sEV by Illumina HiSeq Sequencing. (A) Volcano plot illustrating miR expression in sEV
relative to WJ-MSC. (B) Heatmap showing the most prevalent miR expressed in WJ-MSC (mean normalized counts >10,000) relative to sEV. (C) Heatmap showing
the most prevalent miR expressed in sEV (mean normalized counts >10,000) relative to WJ-MSC. (D) Venn plot summarizing the datasets of miR, which were
significantly up-regulated in sEV (EV up) compared to WJ-MSC, significantly down-regulated in sEV (EV down) relative to WJ-MSC, and highly abundant in sEV
(EV >10,000 counts) and WJ-MSC (WJ-MSC >10,000 counts).
factor Nkx2.2, PDGFRα has been previously shown to be a
key inducer of oligodendrocyte differentiation in the developing
brain (Zhu et al., 2014). The simultaneous up-regulation of the
mature oligodendrocyte marker MBP in sEV-treated MO3.13
cells strongly indicates that the cells matured into premyelinating
oligodendrocytes.
Suprisingly, the maturation of MO3.13 cells was not
accompanied by a reduced proliferation. There was even a trend
to an increased expression of the proliferation marker PCNA in
MO3.13 cells after sEV-treatment for 5 days. This observation
may be explained by the recent finding of Lei and coworkers
that sEV derived from MSC of umbilical cords deliver functional
PCNA to their target cells (Lei et al., 2021). They further approved
that the deposition of PCNA in target cells is partly responsible
for the rejuvenating effects of umbilical cord-derived MSC-sEV.
The oligodendrocyte specification of neural stem/progenitor
cells, as well as their maturation from OPC, are tightly regulated
processes based on the activation or inhibition of specific
signaling pathways and their intersections. Whereas activated
Notch signaling has been identified as an essential step in neural
stem/progenitor cells for oligodendrocyte specification (Kagawa
et al., 2001), the Notch signaling has to be blocked for the
differentiation of OPC into mature oligodendrocytes (Wang
et al., 1998). Notch receptor activation, including the intracellular
cleavage and nuclear translocation of NICD, primarily blocks
OPC differentiation by the transcription of the target gene
HES5 (Liu et al., 2006) (Figure 6). Thereby HES5 associates
with the transcription factor SOX10, preventing the binding
of SOX10 to the promotor of MBP and the induction of its
transcription. In the present study, we show that WJ-MSC-
derived sEV significantly reduced the cleavage of NICD in
the oligodendrocyte precursor cell line MO3.13 after 5 days
of co-culture. Furthermore, the transcription of NOTCH1 and
NOTCH2, and HES5 were reduced, corroborating that the sEV-
mediated maturation of MO3.13 cells is regulated by the reduced
activation of Notch signaling.
A further key pathway negatively regulating OPC maturation
is the MAPK/ERK pathway, which has also been shown to
intersect with Notch signaling (Sundaram, 2005) (Figure 6). The
MAPK/ERK signaling pathway has been previously identified as
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FIGURE 5 | Functional analysis of WJ-MSC-derived sEV miR. (A,B) Scatter plot of the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment
analysis of sEV miR (mean normalized counts >10,000) subdivided into general pathways (A) and disease-related pathways (B). (C) miR-mRNA interaction network
of sEV miRs (yellow) and their target genes (red) being relevant in oligodendrocyte maturation.
a main negative regulator of myelination in the demyelinating
diseases multiple sclerosis (Suo et al., 2019), the Costello
syndrome, and neurofibromatosis type 1, which are Rasopathies
caused by germline mutations in genes encoding for members
of the MAPK pathway including HRAS (HRas proto-oncogene,
GTPase) (Lopez-Juarez et al., 2017; Titus et al., 2017).
The multiple sclerosis model has demonstrated that the
inhibition of MAPK/ERK cascade was enough to drive OPC
differentiation (Suo et al., 2019). In the Costello syndrome and
neurofibromatosis type 1 models, it has been shown that besides
the blockade of MAPK/ERK pathways, the inhibition of the
downstream Notch cascade, either separately or collectively with
MAPK/ERK, improved the myelin structure (Lopez-Juarez et al.,
2017; Titus et al., 2017). Here, we found that the maturation
of MO3.13 cells upon exposure to WJ-MSC-derived sEV was
also mediated by reduced ERK phosphorylation and the down-
regulated transcription of genes encoding for NRAS and ERK2
(MAPK1). We also recently showed such a WJ-MSC sEV-
mediated inhibition of MAPK/ERK signaling in microglial cells
in an in vitro model of neuroinflammation (Thomi et al., 2019b).
Based on these results and the importance of miR during
neuroregeneration in premature WMI (Cho et al., 2019), we
performed Illumina HiSeq sequencing, to characterize the miR
content of WJ-MSC and WJ-MSC-derived sEV. We detected
several highly abundant miR in WJ-MSC and in their derived
sEV. Although several miR were expressed to different degrees
in sEV and cells, the most abundant miR in both cells
and sEV was miR-22-3p. Previously, miR-22-3p has been
characterized as being neuroprotective by inhibiting neuronal
apoptosis (Jovicic et al., 2013; Ma et al., 2016), which can
Frontiers in Cell and Developmental Biology | www.frontiersin.org 10 March 2021 | Volume 9 | Article 622539
fcell-09-622539 March 17, 2021 Time: 18:52 # 11
Joerger-Messerli et al. Cord sEV Promote OPC Maturation
explain—at least partially–the anti-apoptotic effect of WJ-MSC-
derived sEV in neurons recently observed by our group in
in vitro and in vivo models of premature WMI (Joerger-Messerli
et al., 2018; Thomi et al., 2019a). In contrast to our study,
Fang and coworkers have identified miR-21-5p as the most
abundant mature miR in umbilical cord MSC and their derived
sEV (Fang et al., 2016). The difference to our results may
rely on slightly varying isolation protocols of both cells and
sEV. However, miR-21-5p was also highly expressed (>10,000
normalized counts) in our WJ-MSC and sEV, indicating a
key function of this miR. It has been well documented that
miR-21-5p had neuroprotective impacts by reducing neuronal
cell death and promoting angiogenesis (Buller et al., 2010; Ge
et al., 2014). Furthermore, it has been published that miR-21-
5p in neuron-derived EV inhibited autophagy-mediated nerve
injury in an in vitro model of traumatic brain injury (Li
et al., 2019), elucidating the functional transfer of miR-21-5p
from EV to cells. However, as miR regulate the expression of
several mRNAs at the same time, and genes might be targeted
by different miR, we do not believe that one miR alone is
responsible for the beneficial impacts of WJ-MSC and WJ-
MSC-derived sEV. Therefore we performed KEGG pathway
enrichment analysis to identify a wider spectrum of pathways
targeted by the 32 most highly abundant sEV miR (>10,000
normalized counts). Thereby, the analysis revealed that the
keratan sulfate biosynthesis was the most enriched pathway. This
is of great interest, as the sulfated glycosaminoglycan keratan
sulfate is known to trigger glial scar formation, thereby inhibiting
axon regeneration after brain injury (Zhang et al., 2006). This
led to our hypothesis that targeting this pathway by sEV miR
FIGURE 6 | Overview summarizing the predicted targets of WJ-MSC-derived sEV miRs in the Notch and MAPK/ERK signaling cascades. Created with
BioRender.com.
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results in reduced formation of glial scars and increased axon
regeneration in our premature WMI rat model. The blocking
of the keratan biogenesis pathway could explain the reduced
glial activation we recently observed in rat pups with premature
WMI intranasally treated with WJ-MSC-derived sEV (Thomi
et al., 2019b). The impact of WJ-MSC-derived sEV miR on
glycosaminoglycans in other diseases was further reflected by the
high rich factor of the proteoglycans in the cancer KEGG pathway
after the analysis of our high-throughput sequencing results.
Glycosaminoglycans have been shown to trigger angiogenesis,
invasion and metastasis of cancer cells involving persistent
ERK1/2 signaling activation (Yang et al., 2009; Afratis et al., 2012).
Several characterized cancer drug candidates have been shown
to successfully block the MAPK/ERK pathway (Burotto et al.,
2014). The restraining of MAPK/ERK signaling activation could
also be a promising therapy approach in premature WMI, as the
activation of MAPK/ERK signaling arrests OPC maturation and
thereby leads to defective myelination in other demyelinating
diseases, as stated before (Titus et al., 2017; Suo et al., 2019).
Our high-throughput sequencing results of WJ-MSC-derived
sEV miR further strongly indicates that the negative effect of
sEV on MAPK/ERK activation in MO3.13 cells may rely on
their miR cargo.
In addition, according to our results, the dorso-ventral axis
formation pathway, which has a crucial function in neuronal
and glial cell development and includes the Notch cascade
(Wada et al., 2000; Kagawa et al., 2001), was significantly
targeted by sEV miR as well. Interestingly, miR-486-5p and miR-
654-3p, which were highly expressed in sEV and significantly
up-regulated relative to their parental cells, are predicted
to target the genes of key players of the MAPK/ERK and
Notch signaling pathways, namely NRAS, and ERK2 (MAPK1)
and NOTCH2. This observation additionally supports the
advantageous use of WJ-MSC-derived sEV over their maternal
cells as a future treatment in premature WMI. However,
22 of the 32 highly expressed sEV miR are predicted to
target either the MAPK/ERK pathway (NRAS, MAPK1), the
Notch cascade (NOTCH1, NOTCH2), or even both (Figure 6),
further accentuating that the sEV miR-mediated regulation
of pathways is a rather cooperative acting than the work of
an individual miR.
Moreover, KEGG pathway enrichment analysis revealed
that WJ-MSC-derived sEV miR target an additional negative
regulator of OPC differentiation, namely the Wnt signaling
pathway. Active canonical Wnt signaling interferes with
oligodendrocyte maturation, thereby slowing down the
generation of myelinating oligodendrocytes (Fancy et al.,
2009; Feigenson et al., 2009).
As hypo-myelination in premature WMI leads to “secondary”
injuries, often affecting demyelinated neurons and axons (Volpe,
2009), future therapy would ideally be multifactorial. As
already mentioned before, our group has recently shown that
both WJ-MSC and their derived sEV have several beneficial
impacts in in vitro and in vivo models of premature WMI.
In particular, we found that the intranasal administration of
WJ-MSC prevented myelination deficits and microgliosis in
neonatal rats with premature WMI (Oppliger et al., 2016).
Most recently, our group could demonstrate that sEV derived
from WJ-MSC reduced glial activation, neuronal apoptosis,
and rat pup mortality and promoted oligodendrocyte lineage
maturation, axon myelination, and learning and memory in
young rats suffering from premature WMI after intranasal
application (Thomi et al., 2019a,b). Based on our high-
throughput sequencing data presented here, we now can provide
powerful indications that miR play major roles in these described
neuroregenerative effects of WJ-MSC and their derived sEV.
For example, we show that the miR of sEV are predicted to
significantly target the TNF signaling pathway, which is known to
contribute to neuroinflammation. The prognosticated targeting
of the p53, apoptosis, and FoxO signaling pathways by sEV
miR (Figure 6) are very likely to play a part in the anti-
apoptotic action of WJ-MSC-derived sEV we recently observed
in neurons (Joerger-Messerli et al., 2018; Thomi et al., 2019a).
MAPK signaling functionally interacts with many of the enriched
pathways, including p53 and FoxO (Wu, 2004; Asada et al., 2007),
highlighting the manifold protective impacts of sEV miR by
blocking MAPK/ERK signaling. However, the functionality of the
sEV miR have to be further validated in future experiments.
CONCLUSION
In conclusion, our study shows that WJ-MSC-derived sEV miR
are key regulators of the Notch and ERK/MAPK signaling
pathways which allows them to drive the maturation of
OPC and pre-oligodendrocytes toward mature myelinating
oligodendrocytes (Figure 6). Furthermore, as WJ-MSC-derived
sEV miR are predicted to target distinct pathophysiological
mechanisms that are involved in premature WMI, we emphasize
that miR are key mediators of WJ-MSC-derived sEV beneficial
effects in premature WMI.
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